The company’s new facilities add a large footprint of state-of-the-art laboratories and office space for scaling up InterVenn’s software development, technical support, clinical research and business development.

Nathan Duval, PhD, Lead Scientist, will present at the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) National Meeting

Following its Series A financing, BioFlyte welcomes national security and public safety executive Todd Sickles as CEO to accelerate productization and market penetration of its disruptive biodetection technology

Aspinity’s power-intelligent analogML solution named 2022 Best of Sensors Awards finalist

Fluent and NanoCellect are able to leverage and combine the unique advantages of our respective technologies to expand the use of single-cell RNA sequencing for rare cell populations.

A strong list of investors including TravelCenters of America Inc., Evergy Ventures, and Anzu Partners joined the oversubscribed $12M round

Several of NTx executives will attend the Biotechnology Innovation Organization (BIO) International Convention taking place at the San Diego Convention Center

With $32 Million in New Capital from Robert Bosch Venture Capital, Renesas, Anzu Partners and Arm, Arduino’s Vision for Universal Innovation Moves from the Garage and Classroom to the Enterprise With New Professional Offerings

Networks will be instrumental in reaching patients and caregivers, making them aware of our platform and realizing its potential

DAWN™ IO Melanoma is commercially available as a unique glycoproteomics laboratory-developed test (LDT) that aids Oncologists in planning treatment for Melanoma

BioSkryb launches an exclusive Early Access Program at AGBT 2022 for ResolveOME and BaseJumper, a bioinformatics platform to accelerate single-cell exploration

Paid demonstration will provide validation of commercial-scale e-Zinc long-duration energy storage system

6K Additive’s sustainably produced powders will be qualified for full industrialization and high-volume production.

Consumers Can Access the Diabetes Risk Test Kit As Well As Other Health and Wellness Tests Through Labcorp OnDemand

The investment is the first of two funding closes, expected to reach over $150M in total, aimed at building a low-cost, sustainable domestic supply chain for battery materials

GelSight will grow its presence in ten countries across Europe and Asia through four new distribution agreements

New financing will fuel international expansion and increase manufacturing capacity for its low power, sunlight-readable, and eye safe reflective LCD technology

Companies commence partnership to utilize NUBURU’s high power, high brightness blue laser technology and Essentium’s metal additive manufacturing platform to speed metal part production

Harvard University spinout advances a unique complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform that opens a new dimension in cell-based screening

Financing from LG Technology Ventures, Shell Ventures, TNSC, Anzu Partners, and Foothill Ventures will help increase market adoption of the company’s proven Liquefied Gas Electrolyte technology

The financing will accelerate field validation and production of the BioTOF™ z200, a bio-aerosol detection system

Award from the Center for Advanced Manufacturing at MassTech will Fund High-Tech Equipment to Recycle Scrap Materials Used in Additive Manufacturing and Battery Production

InterVenn to Showcase Novel Translational Research Opportunities Based on Glycoproteomics at AACR 2022

e-Zinc Secures USD $25 Million in Series A Financing to Advance Long-Duration Energy Storage

Codetta Biosciences Announces $15 Million in Series A Financing

Funding will be utilized to expand commercial operations and support new product development

The new U.S. patent covers NTx’s inventive in vitro cell-free expression system that overcomes the cost and timeline challenges faced by traditional systems

James Almas, MD, has joined the company’s Board of Advisors to advise on reimbursement strategy, health economics, coding, and other foundational activities required for commercialization of novel diagnostic tests for the clinical market.

Moku:Go and Moku:Pro to Introduce New Capabilities and Improve Usability for Students, Scientists and Engineers

Three-time public company CFO joins NUBURU with deep experience in leading business transformation and optimization of financial processes on a global scale

Published in Angewandte Chemie International Edition, researchers found that quantum computing methods can accurately predict the colour of light emission from OLED emitter materials

The new material, produced on 6K’s UniMelt® microwave plasma production system, will be used in ONE’s range-extended Gemini battery system.

Investment to accelerate next-generation Clean Earth Magnet™ development for use in hard disk drives for enterprise cloud storage, data centers and more

ImmunoScape will utilize Pure MHC’s library of T cell antigens specific to tumor cells to accelerate identification of novel T cell receptors using its Deep Immunomics platform

The agreement combines industry-leading technologies, enabling single cell selection and genome sequencing, and supports the development of intact tissue sample analysis

NTx has received a grant from the Bill & Melinda Gates Foundation to develop new production approaches to lower the cost and improve access to mRNA vaccines and therapeutics for low- and middle-income countries

MAKO and Magic Leap founder Rony Abovitz and experienced executive and investor Elliot Katzman will help shape GelSight’s strategy and reach

First-in-human trial is now open for enrollment for EBT-101, a CRISPR-based therapeutic being developed as a potential functional cure for people living with HIV

Beyond Imagination and GelSight have initiated a pilot to study the feasibility of using Beyond Imagination’s humanoid robotic technology to remotely operate GelSight’s tactile sensors.

Additional growth capital brings NUBURU’s valuation to approximately $350M and executive appointments will accelerate commercialization of its blue laser technology

Klaus has served so far as the company’s Chief Medical and Scientific Officer and will now focus on serving as InterVenn’s scientific alliance ambassador to the global glycobiology constituency.

Mr. Liddy brings over 30 years of executive leadership, IPO and private equity experience, and board involvement with Abbott Laboratories, AbbVie, and Boeing to help guide NTx’s commercialization efforts

Albemarle to invest in 6K and sponsor development of UniMelt® system for advanced, sustainable materials production

This appointment brings peerless experience as a previous board member of Boeing, 3M, Abbott and Goldman Sachs to support 6K’s accelerated growth

First independent Battery Index provides the ‘missing link’ for manufacturers of battery-powered products from consumer electronics to EVs

Thall brings 30+ years of computer technology experience with Microsoft, Verizon and Visteon

Life sciences industry veteran brings decades of experience in public and private companies to scale the company’s capabilities and operations for accelerated growth

InterVenn Biosciences is scheduled to present at the J.P. Morgan 40th Annual Healthcare Conference on January 12, 2022.